International Conference for the Society for Integrative Oncology

综合肿瘤学会国际会议

基本信息

项目摘要

DESCRIPTION (provided by applicant): Through its annual conferences, the Society for Integrative Oncology (SIO) provides a significant forum for presentation of current research and ground-breaking clinical applications of Complementary and Alternative Medicine (CAM) therapies in cancer care. Moreover, these conferences provide an atmosphere conducive to the exchange of important information, while promoting a deeper appreciation of how CAM can combine with conventional approaches in medicine to achieve optimal therapeutic outcomes for cancer patients. These objectives work in accordance with the mission of the NIH, as a mechanism of "science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability." These critical, high-level scientific conferences have been held annually since 2005, providing meaningful, current data on the integration of CAM modalities in the conventional care of cancer patients. This year, the venue is again New York -home to an expansive, forward thinking medical population that includes researchers and clinicians from some of the most prestigious traditional and complementary medicine training and research programs in the country. The large number of local CAM professionals is thus leveraged not only as a potential audience, but as members of the Faculty. The non-profit Society for Integrative Oncology (SIO) was established to be the prime driving force for the reasoned application of evidence-based CAM therapies into conventional cancer care. The SIO is the main sponsor of this conference; the Scientific Program Committee includes senior professionals from major cancer centers throughout the United States and member countries. We anticipate over 300 attendees, primarily active CAM and conventional practitioners involved in cancer patient care. A large minority of oncologists is expected to take part. The specific aims of this application are to establish an annual evidence-based meeting to: 1) introduce recent clinical and basic science evidence regarding Integrative therapies in cancer care to new and established investigators; 2) promote collaboration between national and international centers of excellence in Integrative Oncology to enhance availability of high quality research in complementary and alternative methods of symptom management; 3) provide continuing education and a forum for exchange of future research ideas between experienced investigators and integrative practitioners. PUBLIC HEALTH RELEVANCE: Complementary and Alternative medical (CAM) therapies are used by a large majority of cancer patients, usually without sufficient research into their mechanisms of action, efficacy, or toxicity. The Society for Integrative Oncology (SIO) is devoted to the prudent research and clinical application of CAM therapies in cancer. The annual SIO International Conference, and the Society's journal, serve as vehicles to review and discuss research and clinical outcomes of CAM use in the oncology milieu.
描述(由申请人提供):通过其年度会议,综合肿瘤学会(SIO)为癌症护理中互补和替代医学(CAM)疗法的当前研究和开创性临床应用提供了重要论坛。此外,这些会议提供了有利于交换重要信息的气氛,同时促进了CAM如何与传统医学方法结合的更深入的了解,以实现癌症患者的最佳治疗结果。这些目标是按照NIH的使命来起作用的,它是“追求有关生活系统的性质和行为的基本知识的科学机制,以及该知识的应用以延长健康的生活并减轻疾病和残疾的负担”。 这些关键的高级科学会议自2005年以来每年举行,提供了有关癌症患者常规护理中CAM模式整合的有意义的,当前的数据。今年,该场地再次​​成为纽约 - 一个庞大的,有思想的医学人群,其中包括来自该国一些最负盛名的传统和补充医学培训和研究计划的研究人员和临床医生。因此,大量当地的CAM专业人员不仅可以作为潜在的受众,而且可以作为教师的成员来利用。建立了非营利综合肿瘤学学会(SIO),是合理地将基于证据的CAM疗法应用于常规癌症护理中的主要驱动力。 SIO是本次会议的主要赞助商;科学计划委员会包括来自美国和成员国主要癌症中心的高级专业人员。 我们预计将有300多名与会者,主要是活跃的CAM和参与癌症患者护理的常规从业者。预计将有少数肿瘤学家参加。 本申请的具体目的是建立一个年度循证会议: 1)介绍了有关癌症护理中综合疗法的最新临床和基础科学证据,向新的和已建立的研究者介绍; 2)促进国家和国际综合肿瘤学卓越中心之间的合作,以增强症状管理补充和替代方法的高质量研究; 3)提供继续教育和一个论坛,以在经验丰富的研究人员和综合从业者之间交换未来的研究思想。 公共卫生相关性:绝大多数癌症患者使用互补和替代医学(CAM)疗法,通常没有足够的研究其作用机理,功效或毒性。综合肿瘤学协会(SIO)致力于对CAM疗法在癌症中的审慎研究和临床应用。年度SIO国际会议和该协会的杂志是肿瘤学环境中CAM使用的研究和临床结果的工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter A S Johnstone其他文献

Stereotactic Body Radiation Therapy versus Conventional External Beam Radiotherapy for Spinal Metastases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
立体定向全身放射治疗与传统外照射治疗脊柱转移瘤:随机对照试验的系统回顾和荟萃分析。
  • DOI:
    10.1016/j.radonc.2023.109914
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Henry C Y Wong;Shing Fung Lee;Adrian Wai Chan;S. Caini;Peter Hoskin;C. B. Simone II;Peter A S Johnstone;Yvette M. van der Linden;J. M. van der Velden;Emily J Martin;S. Alcorn;Candice Johnstone;J. Isabelle Choi;Gustavo Nader Marta;E. Oldenburger;S. Raman;A. Rembielak;V. Vassiliou;Pierluigi Bonomo;Q. Nguyen;Edward L. Chow;S. Ryu
  • 通讯作者:
    S. Ryu

Peter A S Johnstone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter A S Johnstone', 18)}}的其他基金

International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7225167
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:
International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7631666
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:
International Conferences of the Society for Integrative Oncology
综合肿瘤学会国际会议
  • 批准号:
    7288364
  • 财政年份:
    2006
  • 资助金额:
    $ 1.2万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于大塑性变形晶粒细化的背压触变反挤压锡青铜偏析行为调控研究
  • 批准号:
    52365047
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
锡(铋、铟)氧/硫化物在CO2电还原过程中的重构行为与催化机制研究
  • 批准号:
    52372217
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
中熵合金低温协同强化及其多场耦合环境下应力腐蚀行为的研究
  • 批准号:
    52371070
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
城市污水厂生物除臭系统生物膜微界面微生物逸散行为及机制
  • 批准号:
    52370026
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
  • 批准号:
    10544369
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Role of PPARg in theFormation and Progression of Carcinoma in situ of the Bladder
BCCMA:暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:PPARg 在膀胱原位癌形成和进展中的作用
  • 批准号:
    10361590
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Role of PPARg in theFormation and Progression of Carcinoma in situ of the Bladder
BCCMA:暴露于致癌物的退伍军人尿路上皮癌症发生的基本和转化机制:PPARg 在膀胱原位癌形成和进展中的作用
  • 批准号:
    10616472
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
(1/2) 庞塞健康科学大学-莫菲特癌症中心合作伙伴关系
  • 批准号:
    10658230
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
Center for Advanced Multi-Omic Characterization of Cancer
癌症高级多组学表征中心
  • 批准号:
    10439370
  • 财政年份:
    2022
  • 资助金额:
    $ 1.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了